ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
-10.45%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$135M
AUM Growth
+$135M
(-53%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-79.88%
Top 10 Holdings %
Top 10 Hldgs %
67.63%
Holding
31
New
1
Increased
3
Reduced
16
Closed
10
Top Buys
| 1 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$5.95M |
| 2 |
Guardant Health
GH
|
$3.64M |
| 3 |
Rapid Micro Biosystems
RPID
|
$1.78M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$1.68M |
Top Sells
| 1 |
Natera
NTRA
|
$25M |
| 2 |
Repligen
RGEN
|
$18.5M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$12.5M |
| 4 |
Sarepta Therapeutics
SRPT
|
$10.8M |
| 5 |
IDEAYA Biosciences
IDYA
|
$10.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
IDEAYA Biosciences
IDYA
$2.26B
| – | – |
-430,000
| Closed | -$10.2M |
|
27
Iovance Biotherapeutics
IOVA
$800M
| – | – |
-406,986
| Closed | -$7.77M |
|
28
Leap Therapeutics
LPTX
$12M
| – | – |
-1,815,000
| Closed | -$5.88M |
|
29
MacroGenics
MGNX
$121M
| – | – |
-30,000
| Closed | -$482K |
|
|
30
Natera
NTRA
$23B
| – | – |
-268,000
| Closed | -$25M |
|
|
31
Repligen
RGEN
$6.54B
| – | – |
-70,000
| Closed | -$18.5M |
|